Regeneron Pharmaceuticals Inc. (REGN)

• Annual Data
• Quarterly Data

• Annual Data
• Quarterly Data

Regeneron Pharmaceuticals Inc., decomposition of ROE (quarterly data)

	ROE	=	ROA	×	Financial Leverage
Sep 30, 2019		=		×
Jun 30, 2019		=		×
Mar 31, 2019		=		×
Dec 31, 2018		=		×
Sep 30, 2018		=		×
Jun 30, 2018		=		×
Mar 31, 2018		=		×
Dec 31, 2017		=		×
Sep 30, 2017		=		×
Jun 30, 2017		=		×
Mar 31, 2017		=		×
Dec 31, 2016		=		×
Sep 30, 2016		=		×
Jun 30, 2016		=		×
Mar 31, 2016		=		×
Dec 31, 2015		=		×
Sep 30, 2015		=		×
Jun 30, 2015		=		×
Mar 31, 2015		=		×
Dec 31, 2014		=		×
Sep 30, 2014		=		×
Jun 30, 2014		=		×
Mar 31, 2014		=		×

Based on: 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07), 10-K (filing date: 2015-02-12), 10-Q (filing date: 2014-11-04), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-05-08).

The primary reason for the decrease in return on equity ratio (ROE) over Q3 2019 is the decrease in profitability measured by return on assets ratio (ROA).

• Annual Data
• Quarterly Data

Regeneron Pharmaceuticals Inc., decomposition of ROE (quarterly data)

	ROE	=	Net Profit Margin	×	Asset Turnover	×	Financial Leverage
Sep 30, 2019		=		×		×
Jun 30, 2019		=		×		×
Mar 31, 2019		=		×		×
Dec 31, 2018		=		×		×
Sep 30, 2018		=		×		×
Jun 30, 2018		=		×		×
Mar 31, 2018		=		×		×
Dec 31, 2017		=		×		×
Sep 30, 2017		=		×		×
Jun 30, 2017		=		×		×
Mar 31, 2017		=		×		×
Dec 31, 2016		=		×		×
Sep 30, 2016		=		×		×
Jun 30, 2016		=		×		×
Mar 31, 2016		=		×		×
Dec 31, 2015		=		×		×
Sep 30, 2015		=		×		×
Jun 30, 2015		=		×		×
Mar 31, 2015		=		×		×
Dec 31, 2014		=		×		×
Sep 30, 2014		=		×		×
Jun 30, 2014		=		×		×
Mar 31, 2014		=		×		×

Based on: 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07), 10-K (filing date: 2015-02-12), 10-Q (filing date: 2014-11-04), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-05-08).

The primary reason for the decrease in return on equity ratio (ROE) over Q3 2019 is the decrease in financial leverage ratio.

• Annual Data
• Quarterly Data

Regeneron Pharmaceuticals Inc., decomposition of ROE (quarterly data)

	ROE	=	Tax Burden	×	Interest Burden	×	EBIT Margin	×	Asset Turnover	×	Financial Leverage
Sep 30, 2019		=		×		×		×		×
Jun 30, 2019		=		×		×		×		×
Mar 31, 2019		=		×		×		×		×
Dec 31, 2018		=		×		×		×		×
Sep 30, 2018		=		×		×		×		×
Jun 30, 2018		=		×		×		×		×
Mar 31, 2018		=		×		×		×		×
Dec 31, 2017		=		×		×		×		×
Sep 30, 2017		=		×		×		×		×
Jun 30, 2017		=		×		×		×		×
Mar 31, 2017		=		×		×		×		×
Dec 31, 2016		=		×		×		×		×
Sep 30, 2016		=		×		×		×		×
Jun 30, 2016		=		×		×		×		×
Mar 31, 2016		=		×		×		×		×
Dec 31, 2015		=		×		×		×		×
Sep 30, 2015		=		×		×		×		×
Jun 30, 2015		=		×		×		×		×
Mar 31, 2015		=		×		×		×		×
Dec 31, 2014		=		×		×		×		×
Sep 30, 2014		=		×		×		×		×
Jun 30, 2014		=		×		×		×		×
Mar 31, 2014		=		×		×		×		×

Based on: 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07), 10-K (filing date: 2015-02-12), 10-Q (filing date: 2014-11-04), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-05-08).

The primary reason for the decrease in return on equity ratio (ROE) over Q3 2019 is the decrease in effect of taxes measured by tax burden ratio.

• Annual Data
• Quarterly Data

Regeneron Pharmaceuticals Inc., decomposition of ROA (quarterly data)

	ROA	=	Net Profit Margin	×	Asset Turnover
Sep 30, 2019		=		×
Jun 30, 2019		=		×
Mar 31, 2019		=		×
Dec 31, 2018		=		×
Sep 30, 2018		=		×
Jun 30, 2018		=		×
Mar 31, 2018		=		×
Dec 31, 2017		=		×
Sep 30, 2017		=		×
Jun 30, 2017		=		×
Mar 31, 2017		=		×
Dec 31, 2016		=		×
Sep 30, 2016		=		×
Jun 30, 2016		=		×
Mar 31, 2016		=		×
Dec 31, 2015		=		×
Sep 30, 2015		=		×
Jun 30, 2015		=		×
Mar 31, 2015		=		×
Dec 31, 2014		=		×
Sep 30, 2014		=		×
Jun 30, 2014		=		×
Mar 31, 2014		=		×

Based on: 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07), 10-K (filing date: 2015-02-12), 10-Q (filing date: 2014-11-04), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-05-08).

The primary reason for the decrease in return on assets ratio (ROA) over Q3 2019 is the decrease in profitability measured by net profit margin ratio.

• Annual Data
• Quarterly Data

Regeneron Pharmaceuticals Inc., decomposition of ROA (quarterly data)

	ROA	=	Tax Burden	×	Interest Burden	×	EBIT Margin	×	Asset Turnover
Sep 30, 2019		=		×		×		×
Jun 30, 2019		=		×		×		×
Mar 31, 2019		=		×		×		×
Dec 31, 2018		=		×		×		×
Sep 30, 2018		=		×		×		×
Jun 30, 2018		=		×		×		×
Mar 31, 2018		=		×		×		×
Dec 31, 2017		=		×		×		×
Sep 30, 2017		=		×		×		×
Jun 30, 2017		=		×		×		×
Mar 31, 2017		=		×		×		×
Dec 31, 2016		=		×		×		×
Sep 30, 2016		=		×		×		×
Jun 30, 2016		=		×		×		×
Mar 31, 2016		=		×		×		×
Dec 31, 2015		=		×		×		×
Sep 30, 2015		=		×		×		×
Jun 30, 2015		=		×		×		×
Mar 31, 2015		=		×		×		×
Dec 31, 2014		=		×		×		×
Sep 30, 2014		=		×		×		×
Jun 30, 2014		=		×		×		×
Mar 31, 2014		=		×		×		×

Based on: 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07), 10-K (filing date: 2015-02-12), 10-Q (filing date: 2014-11-04), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-05-08).

The primary reason for the decrease in return on assets ratio (ROA) over Q3 2019 is the decrease in effect of taxes measured by tax burden ratio.

• Annual Data
• Quarterly Data

Regeneron Pharmaceuticals Inc., decomposition of net profit margin ratio (quarterly data)

	Net Profit Margin	=	Tax Burden	×	Interest Burden	×	EBIT Margin
Sep 30, 2019		=		×		×
Jun 30, 2019		=		×		×
Mar 31, 2019		=		×		×
Dec 31, 2018		=		×		×
Sep 30, 2018		=		×		×
Jun 30, 2018		=		×		×
Mar 31, 2018		=		×		×
Dec 31, 2017		=		×		×
Sep 30, 2017		=		×		×
Jun 30, 2017		=		×		×
Mar 31, 2017		=		×		×
Dec 31, 2016		=		×		×
Sep 30, 2016		=		×		×
Jun 30, 2016		=		×		×
Mar 31, 2016		=		×		×
Dec 31, 2015		=		×		×
Sep 30, 2015		=		×		×
Jun 30, 2015		=		×		×
Mar 31, 2015		=		×		×
Dec 31, 2014		=		×		×
Sep 30, 2014		=		×		×
Jun 30, 2014		=		×		×
Mar 31, 2014		=		×		×

Based on: 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07), 10-K (filing date: 2015-02-12), 10-Q (filing date: 2014-11-04), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-05-08).

The primary reason for the decrease in net profit margin ratio over Q3 2019 is the decrease in effect of taxes measured by tax burden ratio.